Odonate therapeutics, inc. (ODT)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Cash flows from operating activities:
Net loss

-113,343

-111,825

-112,737

-110,036

-100,724

-88,960

-75,943

-62,389

-46,899

-32,744

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation expense

11,105

11,444

10,641

10,036

8,635

6,721

5,761

5,474

4,186

3,184

0

0

0

Depreciation and amortization

353

381

388

470

424

350

0

0

0

-

-

-

-

Non-cash contributions for expenses

-

-

-

-

-

64

146

188

1,110

1,812

0

0

0

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

0

Changes in operating assets and liabilities:
Prepaid expenses and other assets

816

2,936

1,754

-99

192

-3,751

1,900

3,580

3,763

4,956

0

0

0

Accounts payable

7,109

4,782

7,135

3,283

2,554

6,392

5,135

3,878

4,450

3,642

0

0

0

Accrued expenses

-1,783

1,516

2,442

7,807

7,121

4,155

6,726

5,090

4,341

3,184

0

0

0

Net cash used in operating activities

-97,375

-96,638

-93,884

-88,341

-81,749

-67,094

-59,402

-50,831

-36,541

-25,858

0

0

0

Purchases of property and equipment

144

166

459

721

1,944

1,907

0

0

0

-

-

-

-

Net cash used in investing activities

-144

-166

-459

-721

-1,944

-1,907

0

0

0

-

-

-

-

Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

9,848

147,321

221,309

221,295

221,447

0

0

0

Proceeds from issuance of common stock under employee stock plans

3,943

3,581

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

139,039

138,677

137,620

118,540

508

10,197

147,744

221,410

221,295

221,447

0

0

0

Net decrease in cash and restricted cash

41,520

41,873

43,277

29,478

-83,185

-58,804

86,715

169,243

184,667

195,506

0

0

0

Supplemental disclosure of cash flow information:
Issuance costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

571

0

0

0

Property and equipment purchases included in accounts payable and accrued expenses

-16

24

-188

-23

81

83

325

168

116

88

0

0

0

Initial recognition of right-of-use lease assets

-

2,215

0

0

0

-

-

-

-

-

-

-

-